A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma

Molecular Medicine

Volumn 17, Issue 3-4, 2011, Pages 281-292

  Cuenca, Alex G ^a   Delano, Matthew J ^a   Kelly Scumpia, Kindra M ^a   Moreno, Claudia ^a   Scumpia, Philip O ^a   LaFace, Drake M ^b   Heyworth, Paul G ^b   Efron, Philip A ^a   Moldawer, Lyle L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CD11B ANTIGEN; CD14 ANTIGEN; CD31 ANTIGEN; CELL PROTEIN; COLONY STIMULATING FACTOR RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; TIR DOMAIN CONTAINING ADAPTOR PROTEIN PRODUCING INTERFERON; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADAPTIVE IMMUNITY; AMINO ACID METABOLISM; ARTICLE; BURN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INFLAMMATION; INJURY; INNATE IMMUNITY; MYELOID DERIVED SUPPRESSOR CEL; MYELOPOIESIS; NITROSYLATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; MYELOID CELLS; SEPSIS; WOUNDS AND INJURIES;

EID: 79952822608     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00178     Document Type: Article

References (63)

1. Bronte V. (2009) Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions. Eur. J. Immunol. 39:2670-2.
2. Gabrilovich DI, Nagaraj S. (2009) Myeloidderived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:162-74.
3. Ostrand-Rosenberg S, Sinha P. (2009) Myeloidderived suppressor cells: linking inflammation and cancer. J. Immunol. 182:4499-506.
4. Murphey ED, et al. (2004) Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock. 21:415-25.
5. Young MR, Newby M, Wepsic HT. (1987) Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res. 47:100-5.
6. Peranzoni E, et al. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22:238-44.
7. Nagaraj S, et al. (2009) Regulatory myeloid suppressor cells in health and disease. Cancer Res. 69:7503-6.
8. Kusmartsev S, Gabrilovich DI. (2005) STAT1 signaling regulates tumor-associated macrophagemediated T cell deletion. J. Immunol. 174:4880-91.
9. Gallina G, et al. (2006) Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116:2777-90.
10. Angulo I, et al. (2000) Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood. 95:212-20.
11. Rossner S, et al. (2005) Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur. J. Immunol. 35:3533-44.
12. Delano MJ, et al. (2007) MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204:1463-74.
13. Movahedi K, et al. (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood. 111:4233-44.
14. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181:5791-802.
15. Zea AH, et al. (2005) Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65:3044-8.
16. Filipazzi P, et al. (2007) Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25:2546-53.
17. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC. (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13:721s-6s.
18. Rodriguez PC, et al. (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69:1553-60.
19. Nagaraj S, Gabrilovich DI. (2007) Myeloidderived suppressor cells. Adv. Exp. Med. Biol. 601:213-23.
20. Corzo CA, et al. (2009) Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 182(9):5693-701.
21. Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. (2004) Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172:989-99.
22. Popovic PJ, Zeh HJ 3rd, Ochoa JB. (2007) Arginine and immunity. J. Nutr. 137:1681S-6S.
23. Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. (2008) Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 222:162-79.
24. Bronte V, Zanovello P. (2005) Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5:641-54.
25. Nagaraj S, et al. (2007) Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med. 13(7):828-35.
26. Bunt SK, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S. (2006) Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176(1):284-90.
27. Pande K, et al. (2009) Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions. Mol. Ther. 17:508-15.
28. Sander LE, et al. (2010) Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207:1453-64.
29. Noel G, et al. (2007) Postburn monocytes are the major producers of TNF-alpha in the heterogeneous splenic macrophage population. Shock. 27:312-9.
30. Noel G, et al. (2010) A ribonucleotide reductase inhibitor reverses burn induced inflammatory defects. Shock. 34:535-44.
31. Noel JG, et al. (2005) Effect of thermal injury on splenic myelopoiesis. Shock. 23:115-22.
32. Noel JG, et al. (2007) Thermal injury elevates the inflammatory monocyte subpopulation in multiple compartments. Shock. 28:684-93.
33. Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S. (2010) Pivotal advance: tumormediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells. J. Leukoc. Biol. 88:839-48.
34. Vuk-Pavlovic S, et al. (2010) Immunosuppressive CD14+HLA-DRlow/monocytes in prostate cancer. Prostate. 70:443-55.
35. Cheng P, et al. (2008) Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 205:2235-49.
36. Ueda Y, Cain DW, Kuraoka M, Kondo M, Kelsoe G. (2009) IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia. J. Immunol. 182:6477-84.
37. Ueda Y, Kondo M, Kelsoe G. (2005) Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J. Exp. Med. 201(11):1771-80.
38. Fearon DT, Locksley RM. (1996) The instructive role of innate immunity in the acquired immune response. Science. 272:50-3.
39. Scumpia PO, et al. (2010) Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J. Immunol. 184:2247-51.
40. Kusmartsev S, et al. (2003) All-trans-retinoic acid eliminates immature myeloid cells from tumorbearing mice and improves the effect of vaccination. Cancer Res. 63:4441-9.
41. Kusmartsev S, et al. (2008) Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin. Cancer Res. 14:8270-8.
42. Greifenberg V, Ribechini E, Rossner S, Lutz MB. (2009) Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 39:2865-76.
43. Fricke I, et al. (2007) Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigenspecific immune responses. Clin Cancer Res. 13:4840-8.
44. Gabrilovich D, et al. (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood. 92:4150-66.
45. Khan SY, et al. (2006) Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood. 108:2455-62.
46. Ozao-Choy J, et al. (2009) The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res. 69:2514-22.
47. Laudanski K, De A, Miller-Graziano C. (2007) Exogenous heat shock protein 27 uniquely blocks differentiation of monocytes to dendritic cells. Eur. J. Immunol. 37:2812-24.
48. Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB. (2006) CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176:2085-94.
49. Scumpia PO, et al. (2007) Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood. 110:3673-81.
50. Scumpia PO, et al. (2005) CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J. Immunol. 175:3282-6.
51. Opal SM, et al. (1999) Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gramnegative sepsis. Blood. 93:3467-72.
52. Hotchkiss RS, et al. (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27:1230-51.
53. Bakker AB, Baker E, Sutherland GR, Phillips JH, Lanier LL. (1999) Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Nat. Acad. Sci. U. S. A. 96:9792-6.
54. Joyce-Shaikh B, et al. (2010) Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J. Exp. Med. 207:579-89.
55. Pan PY, et al. (2008) Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood. 111:219-28.
56. Zhu B, et al. (2007) CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 179:5228-37.
57. Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. (2001) Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166:5398-406.
58. Sinha P, Clements VK, Ostrand-Rosenberg S. (2005) Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174:636-45.
59. Dolcetti L, et al. (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40:22-35.
60. Huang B, et al. (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 6:1123-31.
61. Umemura N, et al. (2008) Tumor-infiltrating myeloid-derived suppressor cells are pleiotropicinflamed monocytes/macrophages that bear M1-and M2-type characteristics. Journal of leukocyte biology. 83:1136-44.
62. Pan PY, et al. (2010) Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 70(1):99-108.
63. Zhou Z, et al. (2010) Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells. 28:620-32.